Prediction of drug clearance in humans from laboratory animals based on body surface area
- PMID: 11808867
- DOI: 10.1007/BF03226379
Prediction of drug clearance in humans from laboratory animals based on body surface area
Abstract
The object of the study was to develop a new allometric equation for clearance from laboratory animals to humans based on body surface area (BSA allometric method). Human clearances for 30 drugs were predicted from animal data obtained from the literature. The results predicted with the method were compared with those observed. The results were also compared with values predicted with clearance versus body weight (BW simple allometric method), the product of brain weight and clearance versus body weight (Cl x BRW method) and the product of maximum life span potential and clearance versus body weight (Cl x MLP method), respectively. Good predictions were found in 21 out of 30 with the BAS allometric method. Both BSA allometric method and BW simple allometric method can give good predictions of clearance in humans for many drugs. Similarly to BW simple allometric method, Cl x BRW method and Cl x MLP method, BSA allometric method may be used to accurately predict human clearance from laboratory animal data.
Similar articles
-
Interspecies scaling: predicting clearance of anticancer drugs in humans. A comparative study of three different approaches using body weight or body surface area.Eur J Drug Metab Pharmacokinet. 1996 Jul-Sep;21(3):275-8. doi: 10.1007/BF03189726. Eur J Drug Metab Pharmacokinet. 1996. PMID: 8980928
-
Prediction of clearance, volume of distribution and half-life by allometric scaling and by use of plasma concentrations predicted from pharmacokinetic constants: a comparative study.J Pharm Pharmacol. 1999 Aug;51(8):905-10. doi: 10.1211/0022357991773320. J Pharm Pharmacol. 1999. PMID: 10504028
-
Prediction of clearance in humans from in vitro human liver microsomes and allometric scaling. A comparative study of the two approaches.Drug Metabol Drug Interact. 2002;19(1):49-64. doi: 10.1515/dmdi.2002.19.1.49. Drug Metabol Drug Interact. 2002. PMID: 12222754
-
The pharmacokinetic principles behind scaling from preclinical results to phase I protocols.Clin Pharmacokinet. 1999 Jan;36(1):1-11. doi: 10.2165/00003088-199936010-00001. Clin Pharmacokinet. 1999. PMID: 9989339 Review.
-
Interspecies scaling: predicting clearance of drugs in humans. Three different approaches.Xenobiotica. 1996 Sep;26(9):887-95. doi: 10.3109/00498259609052491. Xenobiotica. 1996. PMID: 8893036 Review.
Cited by
-
A comparison of exogenous and endogenous CEST MRI methods for evaluating in vivo pH.Magn Reson Med. 2018 May;79(5):2766-2772. doi: 10.1002/mrm.26924. Epub 2017 Oct 11. Magn Reson Med. 2018. PMID: 29024066 Free PMC article.
-
The conduct of drug metabolism studies considered good practice (I): analytical systems and in vivo studies.Curr Drug Metab. 2007 Dec;8(8):815-21. doi: 10.2174/138920007782798153. Curr Drug Metab. 2007. PMID: 18220562 Free PMC article. Review.
-
Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI.Magn Reson Med. 2014 Nov;72(5):1408-17. doi: 10.1002/mrm.25053. Epub 2013 Nov 26. Magn Reson Med. 2014. PMID: 24281951 Free PMC article.